Evidence map›Paper›PMID 34830096›Full record

ReviewInternational journal of molecular sciences2021

Role of Salivary MicroRNA and Cytokines in the Diagnosis and Prognosis of Oral Squamous Cell Carcinoma.

Francisco Javier Manzano-Moreno, Victor J Costela-Ruiz, Enrique García-Recio, Maria Victoria Olmedo-Gaya, Concepción Ruiz, Candelaria Reyes-Botella

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Caveolin-1 modulates cisplatin sensitivity in oral squamous cell carcinoma through ferroptosis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. CaCOJournal of dental research · 2024
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Francisco Javier Manzano-MorenoBiomedical Group (BIO277), Department of Stomatology, School of Dentistry, University of Granada, 18071 Granada, Spain.
Victor J Costela-RuizInstituto Investigación Biosanitaria, ibs.Granada, 18071 Granada, Spain.ORCID 0000-0001-7285-6615
Enrique García-RecioInstituto Investigación Biosanitaria, ibs.Granada, 18071 Granada, Spain.
Maria Victoria Olmedo-GayaDepartment of Stomatology, School of Dentistry, University of Granada, 18071 Granada, Spain.
Concepción RuizInstituto Investigación Biosanitaria, ibs.Granada, 18071 Granada, Spain.ORCID 0000-0003-4332-6812
Candelaria Reyes-BotellaBiomedical Group (BIO277), Department of Stomatology, School of Dentistry, University of Granada, 18071 Granada, Spain.ORCID 0000-0002-1885-2119

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral squamous cell carcinoma (OSCC) is the most prevalent oral malignant tumor worldwide. An early diagnosis can have a major positive impact on its prognosis. Human saliva contains cytokines, DNA and RNA molecules, circulating cells, and derivatives of tissues and extracellular vesicles, among other factors that can serve as biomarkers. Hence, the analysis of saliva may provide useful information for the early diagnosis of OSCC for its prognosis. The objective of this review was to determine the potential usefulness of salivary biomarkers (cytokines and microRNA) to diagnose OSCC and improve its prognosis. A combination of salivary miRNA and proteomic data could allow a definitive and early diagnosis to be obtained. However, there remains a need to optimize and standardize the protocols used to quantify miRNAs.

Indexed as

Mouth NeoplasmsSquamous Cell Carcinoma of Head and NeckBiomarkers, TumorCytokinesHumansMicroRNAsNeoplasm ProteinsPrognosisRNA, NeoplasmSalivaSalivary Proteins and PeptidesBiomarkers, TumorCytokinesMicroRNAsNeoplasm ProteinsRNA, NeoplasmSalivary Proteins and PeptidescytokinesdiagnosismicroRNAoral canceroral pathologysalivary biomarker

Identifiers

PMID34830096
PMCPMC8624198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.